JAIDS all-PEPFAR supplement is free online and gives a past, present, future look at the President’s Emergency Plan For AIDS Relief as a historic effort that can still look forward to its greatest accomplishments. While the emphasis is on the program’s successes and a pre-AIDS 2012 panel discussion was light on the “lessons learned” from […]
Remember when one of the objections to rolling out life-saving treatment to people living with HIV in developing countries was that lack of capacity to maintain treatment would lead to drug resistance on a massive scale? While that didn’t happen at the scary levels projected, the transmission of drug resistant strains of HIV continue to […]
It was one thing to say we can end the AIDS epidemic, another to say how. Now, with advances in science and years of experience pointing to an evidence-based path, 60 organizations – including those that Science Speaks operates in the midst of, Infectious Diseases Society of America and HIV Medicine Association — and one […]
The U.S. Food and Drug Administration has approved the antiretroviral drug Truvada, to be used as a preexposure preventive measure by people who, uninfected, may be exposed to the virus through HIV-positive partners. The drug previously was approved to treat people living with HIV. As a preventive measure the drug would be taken daily, by […]
This week’s New England Journal of Medicine showcases the results of clinical trials testing the use of antiretroviral drugs to prevent HIV acquisition in uninfected individuals. The results, which have been widely reported at major conferences, are mixed. An article by Lut Van Damme and colleagues reports on the primary results of the Preexposure Prophylaxis […]
Pointing to mounting evidence of the impact of tuberculosis on the health of pregnant women and their children, the President’s Emergency Plan For AIDS Relief is recommending improvements to efforts to detect the disease in settings offering health services to pregnant women, women with HIV, newborns, and children. “Recent studies have shown that HIV-infected pregnant […]
CDC’s Grand Rounds feature examines past, future of HIV/TB response: In a world where an estimated 160 people die of tuberculosis every hour, where 25 percent of HIV/AIDS-related deaths are caused by TB, and where 9 million people can be expected to develop the disease each year, while untreatable forms of infection have emerged, “much […]
It was a global health Catch-22: Women’s ability to prevent unintended pregnancies is pivotal to the fight against HIV, but researchers had deduced that one of the most widely used and effective methods of contraception in areas hardest hit by the epidemic could increase transmission of the virus. Research released last year, following earlier studies […]
The potential for antiretroviral medicine to reduce transmission of HIV and tuberculosis has been demonstrated, but the challenges of using treatment to prevent infection will need to be tackled country by country, and with focus on people for whom it will have the biggest impact, the latest bulletin on HIV treatment from the World Health […]
There is a pervasive pattern of stockouts of condoms, both male and female condoms, in African countries confronting HIV/AIDS, according to Carolyn Ryan, MD, MPH, director of technical leadership at the Office of the Global AIDS Coordinator (OGAC).
She called the condom gap “really quite disturbing,” given that condoms are a crucial tool for HIV prevention. While HIV incidence has fallen in recent years, in 2009 there were an estimated 2.6 million people newly infected with HIV, meaning that about 7000 people are acquiring the infection each day.